alpha-aminopyridine has been researched along with prednisone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisen, D; Lynch, DP | 1 |
| Bhat, BG; Chapman, J; Fanjul, A; Herrera, J; Hosea, N; Rejto, PA; Stewart, PM; Thalacker, F | 1 |
| Calle, RA; Courtney, R; Hirshberg, B; Ndongo, MN; Stewart, PM; Toh, M | 1 |
| Augustine, EF; Mink, JW | 1 |
| Chen, Z; Li, Y; Tian, C | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Cai, Q; Song, W; Sun, X; Wang, L; Wang, Y; Xue, H; Zhang, H; Zhang, L; Zhang, M; Zou, L | 1 |
| Aggarwal, R; Carneiro, BA; de Kouchkovsky, I; Fong, L; Friedlander, T; Lewis, C; Paris, PL; Phone, A; Rao, A; Ryan, CJ; Small, EJ; Szmulewitz, RZ; Zhang, L | 1 |
2 review(s) available for alpha-aminopyridine and prednisone
| Article | Year |
|---|---|
Selecting topical and systemic agents for recurrent aphthous stomatitis.
Topics: Administration, Topical; Aminopyridines; Anti-Inflammatory Agents; Humans; Prednisone; Recurrence; Stomatitis, Aphthous | 2001 |
Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies.
Topics: Aminopyridines; Anti-Inflammatory Agents; Genetic Therapy; Humans; Immunosuppressive Agents; Membrane Glycoproteins; Molecular Chaperones; Mycophenolic Acid; Neuronal Ceroid-Lipofuscinoses; Prednisone | 2016 |
3 trial(s) available for alpha-aminopyridine and prednisone
| Article | Year |
|---|---|
Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Oral; Adolescent; Adult; Aminopyridines; Biomarkers; Cortisone; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Prednisolone; Prednisone; Sulfonamides | 2008 |
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia; Prednisone; Thalidomide; Treatment Outcome | 2022 |
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase 4; Docetaxel; Febrile Neutropenia; Humans; Male; Prednisone; Prostatic Neoplasms, Castration-Resistant; Purines; Treatment Outcome | 2022 |
3 other study(ies) available for alpha-aminopyridine and prednisone
| Article | Year |
|---|---|
Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4'-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11 -hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Aminopyridines; Animals; Biomarkers; Cell Line; Cells, Cultured; Cortisone; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Hydrocortisone; Insulin; Macaca fascicularis; Male; Prednisolone; Prednisone; Protein Serine-Threonine Kinases; Sulfonamides; Transfection | 2008 |
Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Topics: Adenine; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Bone Marrow Cells; China; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Prognosis; Rituximab; Transplantation, Autologous; Vincristine | 2020 |
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |